Professor Anthony Wierzbicki
Disclosure details
Site clinical trial investigator for Akcea (Volanesorsen); Regeneron (evinacumab) in Familial Chylomicronaemia Syndrome. Site trial co-investigator evolocumab in chronic coronary disease (VESALIUS).Consultant in Metabolic Medicine/Chemical Pathology at Guy’s & St. Thomas’ Hospitals, London
Honorary Professor in Cardiometabolic Disease at King’s College, London
